Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEPTRALU, Spanish Series of Patients Treated With the Radionuclide Lutetium177

NCT04949282 is registered in ClinicalTrials.gov with Sociedad Española de Medicina Nuclear e Imagen Molecular as lead sponsor.

NCT NCT04949282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04949282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEPTRALU, Spanish Series of Patients Treated With the Radionuclide Lutetium177
Lead sponsor
Sociedad Española de Medicina Nuclear e Imagen Molecular
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2021
Completion date
December 31, 2035
Enrollment
5,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system diseases, digestive system neoplasms, endocrine gland neoplasms, endocrine system diseases, gastrointestinal disease, gastrointestinal neoplasms, intestinal diseases, intestinal neoplasms, neoplasms, neoplasms by histologic type, neoplasms by site, neoplasms, germ cell and embryonal, neoplasms, nerve tissue, neuroectodermal tumors, neuroendocrine tumors, pancreatic disease, pancreatic neoplasms, stomach neoplasms